Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Sell
12,336
-291,573
-96% -$77.5M ﹤0.01% 2176
2026
Q1
$46M Sell
303,909
-1,060,192
-78% -$129M 0.01% 693
2025
Q4
$149M Buy
1,364,101
+452,725
+50% +$65.8M 0.04% 312
2025
Q3
$129M Buy
+911,376
New +$133M 0.03% 342
2025
Q1
Sell
-521,174
Closed -$64.3M 3280
2024
Q4
$64.3M Hold
521,174
0.02% 540
2024
Q3
$74.5M Hold
521,174
0.02% 500
2024
Q2
$85.3M Buy
521,174
+133,672
+34% +$16.6M 0.02% 452
2024
Q1
$48.4M Buy
+387,502
New +$41.1M 0.01% 646

Other funds holding ARM

Nuveen's ARM Position: Q2 2026 in Review

Nuveen reduced its Arm (ARM) stake by 96% in Q2 2026, selling an estimated $77.5M and leaving 12,336 shares worth $4.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Nuveen first reported a position in ARM in Q1 2024 and has held it in 8 quarters since. The position peaked at $149M in Q4 2025. 956 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • Nuveen held 12,336 shares of Arm worth $4.37M as of Q2 2026.
  • Nuveen sold 291,573 Arm shares in Q2 2026, an estimated $77.5M.
  • Arm made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2176 holding.
  • Nuveen first reported a position in Arm in Q1 2024 and has held it in 8 quarters since.
  • Nuveen's Arm position peaked at $149M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.